Article
Adenovirus type-35 vectors block human CD4 <sup>+</sup> T-cell activation via CD46 ligation
18 Apr 2011
Abstract excerpt
Recombinant adenoviruses (rAds) based on types 5 (rAd5) and 35 (rAd35) have emerged as important vaccine delivery vectors in clinical testing for a variety of pathogens. A major difference between these vectors is their binding to cellular receptors used for infection. Whereas rAd5 binds coxsackie-adenovirus receptor (CAR), rAd35 binds the complement regulatory protein CD46. Although rAd35 infected and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
